{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:00:17Z","timestamp":1790398817518,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neulet.2019.134445","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:37:10Z","timestamp":1566643030000},"page":"134445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Neuropathic pain in individuals with sickle cell disease"],"prefix":"10.1016","volume":"714","author":[{"given":"Deva","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Brandow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9861","key":"10.1016\/j.neulet.2019.134445_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle-cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0015","doi-asserted-by":"crossref","first-page":"e1248273","DOI":"10.1080\/21690707.2016.1248273","article-title":"Understanding the roles of intrinsic disorder in subunits of hemoglobin and the disease process of sickle cell anemia","volume":"4","author":"Fitzsimmons","year":"2016","journal-title":"Intrinsically Disord. Proteins"},{"issue":"10","key":"10.1016\/j.neulet.2019.134445_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.21408","article-title":"The cost of health care for children and adults with sickle cell disease","volume":"84","author":"Kauf","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"13","key":"10.1016\/j.neulet.2019.134445_bib0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AJP.0000000000000289","article-title":"Psychosocial and functional outcomes in youth with chronic sickle cell pain","volume":"32","author":"Sil","year":"2016","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/JPR.S150065","article-title":"Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease","volume":"11","author":"Bakshi","year":"2018","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pbc.22222","article-title":"Vaso-occlusive painful events in sickle cell disease: impact on child well-being","volume":"54","author":"Brandow","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"issue":"26","key":"10.1016\/j.neulet.2019.134445_bib0055","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood-2014-08-435768","article-title":"Update on the use of hydroxyurea therapy in sickle cell disease","volume":"124","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.neulet.2019.134445_bib0060","unstructured":"FDA, Approved l-Glutamine Powder for the Treatment of Sickle Cell Disease. (Cited 1 October 2017). Available from: https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm566097.htm."},{"issue":"22","key":"10.1016\/j.neulet.2019.134445_bib0065","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2017-05-782003","article-title":"Targeting novel mechanisms of pain in sickle cell disease","volume":"130","author":"Tran","year":"2017","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2019.134445_bib0070","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","article-title":"Sickle cell disease: a natural model of acute and chronic pain","volume":"158","author":"Brandow","year":"2017","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pmn.2017.11.010","article-title":"Differences in sensory pain, expectation, and satisfaction reported by outpatients with cancer or sickle cell disease","volume":"19","author":"Ezenwa","year":"2018","journal-title":"Pain Manag. Nurs."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0085","unstructured":"IASP, Taxonomy: Neuropathic Pain. (1 October 2017). Available from: http:\/\/www.iasp-pain.org\/Education\/Content.aspx?ItemNumber=1698-Neuropathicpain."},{"key":"10.1016\/j.neulet.2019.134445_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","article-title":"Mechanisms of neuropathic pain","volume":"52","author":"Campbell","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/87.1.12","article-title":"Mechanisms of neuropathic pain","volume":"87","author":"Bridges","year":"2001","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2011.05.005","article-title":"Mechanisms of neuropathic pain","volume":"22","author":"Nickel","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician","volume":"175","author":"Gilron","year":"2006","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pain.2006.10.034","article-title":"Using screening tools to identify neuropathic pain","volume":"127","author":"Bennett","year":"2007","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0120","doi-asserted-by":"crossref","first-page":"e1000045","DOI":"10.1371\/journal.pmed.1000045","article-title":"Tools for assessing neuropathic pain","volume":"6","author":"Cruccu","year":"2009","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0014-4886(76)90271-5","article-title":"Classification of clinical pain descriptions by multiple group discriminant analysis","volume":"51","author":"Dubuisson","year":"1976","journal-title":"Exp. Neurol."},{"issue":"18","key":"10.1016\/j.neulet.2019.134445_bib0130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neulet.2019.134445_bib0135","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","article-title":"Neuropathic pain: an updated grading system for research and clinical practice","volume":"157","author":"Finnerup","year":"2016","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.neulet.2019.134445_bib0140","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","article-title":"Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms","volume":"13","author":"Jensen","year":"2014","journal-title":"Lancet Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.neulet.2019.134445_bib0145","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"issue":"1-3","key":"10.1016\/j.neulet.2019.134445_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","article-title":"Pathobiology of neuropathic pain","volume":"429","author":"Zimmermann","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pain.2011.08.015","article-title":"Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats","volume":"153","author":"Serra","year":"2012","journal-title":"Pain"},{"issue":"Suppl. 1","key":"10.1016\/j.neulet.2019.134445_bib0170","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.neuroimage.2007.03.054","article-title":"Brain imaging of neuropathic pain","volume":"37","author":"Moisset","year":"2007","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11916-009-0033-x","article-title":"Role of skin biopsy in the diagnosis of peripheral neuropathic pain","volume":"13","author":"Walk","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"issue":"December (6)","key":"10.1016\/j.neulet.2019.134445_bib0180","first-page":"210","article-title":"MIBAonp","volume":"8","author":"Callin","year":"2008","journal-title":"Contin. Educ. Anaesth. Crit. Care Pain"},{"issue":"7335","key":"10.1016\/j.neulet.2019.134445_bib0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmj.324.7335.466","article-title":"Peripheral neuropathy","volume":"324","author":"Hughes","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.neulet.2019.134445_bib0190","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.neulet.2019.134445_bib0195","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.neulet.2019.134445_bib0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ajh.23575","article-title":"Neuropathy, neuropathic pain, and sickle cell disease","volume":"88","author":"Ballas","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.neulet.2019.134445_bib0205","first-page":"8628425","article-title":"Ischemic monomeric neuropathy in a woman with sickle cell anaemia","volume":"2016","author":"Agapidou","year":"2016","journal-title":"Case Rep. Hematol."},{"issue":"7","key":"10.1016\/j.neulet.2019.134445_bib0210","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-1331.2009.02592.x","article-title":"Peripheral nervous system involvement in patients with sickle cell disease","volume":"16","author":"Okuyucu","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/aet269","article-title":"Is sickle cell disease a possible risk factor for peripheral neuropathy after popliteal sciatic nerve block?","volume":"111","author":"Giabicani","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcn\/84.3.483","article-title":"Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA\/KORA Augsburg cohort study","volume":"84","author":"Meisinger","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0225","first-page":"18","article-title":"Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease","volume":"102","author":"Wilkie","year":"2010","journal-title":"J. Med. Assoc."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pbc.24838","article-title":"Neuropathic pain in patients with sickle cell disease","volume":"61","author":"Brandow","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/papr.12279","article-title":"Safety and utility of quantitative sensory testing among adults with sickle cell disease: indicators of neuropathic pain?","volume":"16","author":"Ezenwa","year":"2016","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.23341","article-title":"Patients with sickle cell disease have increased sensitivity to cold and heat","volume":"88","author":"Brandow","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.neulet.2019.134445_bib0245","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pbc.25574","article-title":"Early insights into the neurobiology of pain in sickle cell disease: a systematic review of the literature","volume":"62","author":"Brandow","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0250","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MPH.0000000000000532","article-title":"Clinical interpretation of quantitative sensory testing as a measure of pain sensitivity in patients with sickle cell disease","volume":"38","author":"Brandow","year":"2016","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0255","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.neulet.2019.134445_bib0260","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.neulet.2019.134445_bib0265","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/j.pain.0000000000000966","article-title":"Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis","volume":"158","author":"Uhelski","year":"2017","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.neulet.2019.134445_bib0270","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcmd.2017.03.005","article-title":"Functional MRI BOLD response in sickle mice with hyperalgesia","volume":"65","author":"Wang","year":"2017","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.neulet.2019.134445_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2016.12.024","article-title":"Characterization of functional brain activity and connectivity using EEG and fMRI in patients with sickle cell disease","volume":"14","author":"Case","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bjh.14300","article-title":"Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use","volume":"175","author":"Brandow","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.neulet.2019.134445_bib0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/asheducation-2010.1.403","article-title":"Neurobiological mechanisms of pain in sickle cell disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0295","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1152\/ajpregu.00021.2018","article-title":"Targeting pain at its source in sickle cell disease","volume":"315","author":"Gupta","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0300","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","article-title":"Diagnosis and assessment of neuropathic pain through questionnaires","volume":"17","author":"Attal","year":"2018","journal-title":"Lancet Neurol."},{"issue":"September (7)","key":"10.1016\/j.neulet.2019.134445_bib0305","article-title":"Diagnosis and classification of neuropathic pain","volume":"XVIII","author":"Ballantyne","year":"2010","journal-title":"Int. Assoc. Study Pain"},{"issue":"1-2","key":"10.1016\/j.neulet.2019.134445_bib0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3959(00)00482-6","article-title":"The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs","volume":"92","author":"Bennett","year":"2001","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neulet.2019.134445_bib0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.neulet.2019.134445_bib0320","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejpain.2008.01.005","article-title":"NeuroQuick\u2014a novel bedside test for small fiber neuropathy?","volume":"12","author":"Haussleiter","year":"2008","journal-title":"Eur. J. Pain"},{"issue":"10","key":"10.1016\/j.neulet.2019.134445_bib0325","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"8","key":"10.1016\/j.neulet.2019.134445_bib0330","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079906X115702","article-title":"Development and testing of a neuropathic pain screening questionnaire: ID Pain","volume":"22","author":"Portenoy","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0335","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1188\/15.CJON.562-567","article-title":"Sickle cell disease in adults: developing an appropriate care plan","volume":"19","author":"Matthie","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"23","key":"10.1016\/j.neulet.2019.134445_bib0340","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neulet.2019.134445_bib0345","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00277-017-2984-z","article-title":"Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults","volume":"96","author":"Antunes","year":"2017","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0355","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1182\/blood.V114.22.2576.2576","article-title":"Neuropathic vs. nociceptive pain in adolescent sickle cell disease (SCD) evaluated by a computer-based self-assessment pain tool","volume":"114","author":"Richard","year":"2009","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.neulet.2019.134445_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2006.03.024","article-title":"Quantitative sensory testing in children: practical considerations for research and clinical practice","volume":"123","author":"McGrath","year":"2006","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0365","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the american academy of neurology","volume":"60","author":"Shy","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0370","first-page":"41","article-title":"Human experimental pain models in drug development: translational pain research","volume":"8","author":"Arendt-Nielsen","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.neulet.2019.134445_bib0375","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/AJP.0b013e3181a68c7e","article-title":"Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities","volume":"25","author":"Backonja","year":"2009","journal-title":"Clin. J. Pain"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0380","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/AJP.0b013e318292a38e","article-title":"Thermal pain and sensory processing in children with sickle cell disease","volume":"30","author":"O\u2019Leary","year":"2014","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0385","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JPR.S150066","article-title":"Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode","volume":"11","author":"Bakshi","year":"2018","journal-title":"J. Pain Res."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0390","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/34.1.61","article-title":"The pain threshold in juvenile chronic arthritis","volume":"34","author":"Hogeweg","year":"1995","journal-title":"Br. J. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2019.134445_bib0400","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pain.2005.12.015","article-title":"Quantitative sensory testing in children with migraine: preliminary evidence for enhanced sensitivity to painful stimuli especially in girls","volume":"123","author":"Zohsel","year":"2006","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0405","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1572-0241.2008.01911.x","article-title":"Somatic pain sensitivity in children with recurrent abdominal pain","volume":"103","author":"Zohsel","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pain.2010.05.002","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes","volume":"150","author":"Maier","year":"2010","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.neulet.2019.134445_bib0415","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1097\/j.pain.0000000000000689","article-title":"Reliability of conditioned pain modulation: a systematic review","volume":"157","author":"Kennedy","year":"2016","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.neulet.2019.134445_bib0420","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jpain.2012.07.005","article-title":"Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis","volume":"13","author":"Lewis","year":"2012","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0425","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pain.2008.05.015","article-title":"Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain\u2014new perspective of opioid-induced hyperalgesia","volume":"139","author":"Ram","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0430","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/j.pain.0000000000000473","article-title":"Quantitative sensory testing and pain-evoked cytokine reactivity: comparison of patients with sickle cell disease to healthy matched controls","volume":"157","author":"Campbell","year":"2016","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0435","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jpainsymman.2011.06.020","article-title":"Detecting the emergence of chronic pain in sickle cell disease","volume":"43","author":"Hollins","year":"2012","journal-title":"J. Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0440","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjh.15876","article-title":"Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities","volume":"185","author":"Miller","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1 Suppl. 1","key":"10.1016\/j.neulet.2019.134445_bib0445","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0450","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10143-016-0807-7","article-title":"Neuroimaging of neuropathic pain: review of current status and future directions","volume":"41","author":"Alomar","year":"2018","journal-title":"Neurosurg. Rev."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0455","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.aco.0000433060.59939.fe","article-title":"Functional MRI and pain","volume":"26","author":"Fomberstein","year":"2013","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"7","key":"10.1016\/j.neulet.2019.134445_bib0460","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00029330-200804010-00015","article-title":"Advances in brain imaging of neuropathic pain","volume":"121","author":"Chen","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-010-2340-1","article-title":"From the neuromatrix to the pain matrix (and back)","volume":"205","author":"Iannetti","year":"2010","journal-title":"Exp. Brain Res."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0470","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11916-011-0187-1","article-title":"How close are we in utilizing functional neuroimaging in routine clinical diagnosis of neuropathic pain?","volume":"15","author":"Borsook","year":"2011","journal-title":"Curr. Pain Headache Rep."},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0475","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","article-title":"Human brain mechanisms of pain perception and regulation in health and disease","volume":"9","author":"Apkarian","year":"2005","journal-title":"Eur. J. Pain"},{"issue":"22","key":"10.1016\/j.neulet.2019.134445_bib0480","first-page":"3656","article-title":"Daily pain is associated with alterations in functional connectivity of the brain on fMRI in adults with sickle","volume":"128","author":"Singavi","year":"2016","journal-title":"Cell Dis."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNP.0b013e3182051334","article-title":"Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients","volume":"28","author":"Erbas","year":"2011","journal-title":"J. Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0490","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.neulet.2019.134445_bib0495","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJM200505053521817","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Sone","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.neulet.2019.134445_bib0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.endonu.2010.05.006","article-title":"Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years\u2019 disease duration","volume":"57","author":"Miralles-Garcia","year":"2010","journal-title":"Endocrinol. Nutr."},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0505","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000000785","article-title":"Risk factors for neuropathic pain in diabetes mellitus","volume":"158","author":"Hebert","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0510","article-title":"Risk factors for incident neuropathic pain in HIV infection: the CHARTER study","volume":"15","author":"Ellis","year":"2009","journal-title":"J. Neurovirol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134445_bib0515","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"J. Pain"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0520","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0525","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/practneurol-2013-000536","article-title":"Neuropathic pain: diagnosis and treatment","volume":"13","author":"Magrinelli","year":"2013","journal-title":"Pract. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1533-2500.2011.00485.x","article-title":"Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature","volume":"12","author":"Vadalouca","year":"2012","journal-title":"Pain Pract."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/papr.12036","article-title":"Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in national clinical practice guidelines from european countries","volume":"14","author":"Piano","year":"2014","journal-title":"Pain Pract."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0540","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0545","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1213\/ANE.0000000000001787","article-title":"Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization","volume":"124","author":"Maher","year":"2017","journal-title":"Anesth. Analg."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0550","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/AJP.0000000000000547","article-title":"A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice","volume":"34","author":"Aiyer","year":"2018","journal-title":"Clin. J. Pain"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0555","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/sjpain-2017-0140","article-title":"Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial","volume":"18","author":"Lubega","year":"2018","journal-title":"Scand. J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0560","first-page":"1","article-title":"Low-dose ketamine infusion for adjunct management during vaso-occlusive episodes in adults with sickle cell disease: a case series","author":"Palm","year":"2018","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.neulet.2019.134445_bib0565","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12887-015-0515-4","article-title":"Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study","volume":"15","author":"Sheehy","year":"2015","journal-title":"BMC Pediatr."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0570","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","article-title":"Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series","volume":"26","author":"Zempsky","year":"2010","journal-title":"Clin. J. Pain"},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0575","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MPH.0000000000000265","article-title":"The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay","volume":"37","author":"Brandow","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.neulet.2019.134445_bib0580","unstructured":"tDCS Associated With Peripheral Electrical Stimulation for Pain Control in Individuals with Sickle Cell Disease (tDCS\/PES_SCD)\u201d ClinicalTrials.gov. (Cited 19 September 2018). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02813629?term=tDCS&cond=sickle&rank=1."},{"issue":"1","key":"10.1016\/j.neulet.2019.134445_bib0585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/j.1532-2149.2012.00167.x","article-title":"The effects of transcranial direct current stimulation with visual illusion in neuropathic pain due to spinal cord injury: an evoked potentials and quantitative thermal testing study","volume":"17","author":"Kumru","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0590","unstructured":"Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease (Cannabis-SCD): ClinicalTrials.gov. (Cited 19 September 2018). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01771731?term=pain&recrs=e&cond=sickle&rank=9."},{"key":"10.1016\/j.neulet.2019.134445_bib0595","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"Mucke","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neulet.2019.134445_bib0600","unstructured":"HealthMeasures: Pain Domains http:\/\/www.healthmeasures.net\/search-view-measures?task=Search.search 2017. Available from: http:\/\/www.healthmeasures.net\/search-view-measures?task=Search.search."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/j.pain.0000000000001099","article-title":"Genetic studies of human neuropathic pain conditions: a review","volume":"159","author":"Zorina-Lichtenwalter","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2019.134445_bib0610","series-title":"Classification of Chronic Pain","author":"Merskey","year":"1994"},{"issue":"5-6","key":"10.1016\/j.neulet.2019.134445_bib0615","first-page":"11","article-title":"The role and treatment implications of peripheral and central processing of pain, pruritus, and nausea in heightened somatic awareness: a review","volume":"14","author":"Spiegel","year":"2017","journal-title":"Innov Clin Neurosci ."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0620","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jpain.2013.01.010","article-title":"Conditioned pain modulation in children and adolescents: effects of sex and age","volume":"14","author":"Tsao","year":"2013","journal-title":"J Pain ."},{"issue":"Suppl 1","key":"10.1016\/j.neulet.2019.134445_bib0625","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/pme.12914","article-title":"Opioid induced hyperalgesia","volume":"16","author":"Yi","year":"2015","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0630","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"16","author":"Colloca","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"9 Suppl","key":"10.1016\/j.neulet.2019.134445_bib0635","first-page":"S256","article-title":"Differential diagnosis: nociceptive and neuropathic pain","volume":"12","author":"Nicholson","year":"2006","journal-title":"Am J Manag Care."},{"issue":"5","key":"10.1016\/j.neulet.2019.134445_bib0640","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/ern.09.34","article-title":"Pain catastrophizing: a critical review","volume":"9","author":"Quartana","year":"2009","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.neulet.2019.134445_bib0645","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1289\/ehp.824423","article-title":"Structure and function of the somatosensory system: a neurotoxicological perspective","volume":"44","author":"Arezzo","year":"1982","journal-title":"Environ Health Perspect."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0650","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1155\/2009\/523098","article-title":"Reliability of temporal summation and diffuse noxious inhibitory control","volume":"14","author":"Cathcart","year":"2009","journal-title":"Pain Res Manag."},{"issue":"1-2","key":"10.1016\/j.neulet.2019.134445_bib0655","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2007.03.015","article-title":"Spatial summation of mechanically evoked muscle pain and painful aftersensations in normal subjects and fibromyalgia patients","volume":"130","author":"Staud","year":"2007","journal-title":"Pain."},{"issue":"1-2","key":"10.1016\/j.neulet.2019.134445_bib0660","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pain.2004.09.041","article-title":"Gender differences in pain modulation evoked by repeated injections of glutamate into the human trapezius muscle","volume":"113","author":"Ge","year":"2005","journal-title":"Pain."},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0665","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0885-3924(02)00638-3","article-title":"Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain","volume":"25","author":"Wilkie","year":"2003","journal-title":"J Pain Symptom Manage."},{"issue":"22","key":"10.1016\/j.neulet.2019.134445_bib0670","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1182\/blood.V128.22.3525.3525","article-title":"Validation of Painreportit Neuropathic Pain Scale in African American Adults with Sickle Cell Disease","volume":"128","author":"Roach","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.neulet.2019.134445_bib0675","doi-asserted-by":"crossref","first-page":"185-9","DOI":"10.1097\/MPH.0000000000000214","article-title":"Sensory and thermal quantitative testing in children with sickle cell disease","volume":"37","author":"Jacob","year":"2015","journal-title":"J Pediatr Hematol Oncol."},{"issue":"10","key":"10.1016\/j.neulet.2019.134445_bib0680","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jpain.2017.05.005","article-title":"Psychological characteristics and pain frequency are associated with experimental pain sensitivity in pediatric patients with sickle cell disease","volume":"18","author":"Bakshi","year":"2017","journal-title":"J Pain."},{"issue":"11","key":"10.1016\/j.neulet.2019.134445_bib0685","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain."},{"issue":"2","key":"10.1016\/j.neulet.2019.134445_bib0690","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/j.pain.0000000000001407","article-title":"Children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity during acute painful events","volume":"160","author":"Brandow","year":"2019","journal-title":"Pain."},{"key":"10.1016\/j.neulet.2019.134445_bib0695","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejphar.2013.10.062","article-title":"Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease","volume":"723","author":"Molokie","year":"2014","journal-title":"Eur J Pharmacol."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0700","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pmn.2017.07.003","article-title":"Management of sickle cell pain using pregabalin: a pilot study","volume":"18","author":"Schlaeger","year":"2017","journal-title":"Pain Manag Nurs."},{"issue":"6","key":"10.1016\/j.neulet.2019.134445_bib0705","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/papr.12674","article-title":"Efficacy and tolerance of lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle cell crises in children: a prospective multicenter clinical study","volume":"18","author":"Rousseau","year":"2018","journal-title":"Pain Pract."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019305488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:27:46Z","timestamp":1759609666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019305488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":141,"alternative-id":["S0304394019305488"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134445","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathic pain in individuals with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134445"}}